Yayın:
Evidence for Medium Chain Triglycerides in the Treatment of Primary Intestinal Lymphangiectasia

dc.contributor.authorGüvenç, B. Haluk
dc.contributor.authorB. Haluk Güvenç
dc.contributor.authorRobert Carachi
dc.contributor.orcid0000-0002-1014-7626
dc.contributor.orcid0000-0001-8025-1747
dc.date.accessioned2025-11-13T09:53:59Z
dc.date.issued2009-05-15
dc.identifier.doihttps://doi.org/10.1055/s-0029-1216389
dc.identifier.endpage245
dc.identifier.issn0939-7248
dc.identifier.issue04
dc.identifier.openalexW2112225762
dc.identifier.startpage241
dc.identifier.urihttps://hdl.handle.net/11421/2533
dc.identifier.urihttps://doi.org/10.1055/s-0029-1216389
dc.identifier.volume19
dc.language.isoen
dc.relation.ispartofEuropean Journal of Pediatric Surgery
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectLymphangiectasia
dc.subjectGastroenterology
dc.subjectInternal medicine
dc.subjectAbnormality
dc.subjectProtein losing enteropathy
dc.subjectSurgery
dc.subjectLymphatic system
dc.subjectPathology
dc.subjectEnteropathy
dc.subjectDisease
dc.subject.sdg3
dc.titleEvidence for Medium Chain Triglycerides in the Treatment of Primary Intestinal Lymphangiectasia
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5060592763

Dosyalar

Koleksiyonlar